Synthesis, Analysis, Cholinesterase-Inhibiting Activity and Molecular Modelling Studies of 3-(Dialkylamino)-2-hydroxypropyl 4-[(Alkoxy-carbonyl)amino]benzoates and Their Quaternary Ammonium Salts
Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články
PubMed
29168793
PubMed Central
PMC6149889
DOI
10.3390/molecules22122048
PII: molecules22122048
Knihovny.cz E-zdroje
- Klíčová slova
- acetylcholinesterase, arylcarbonyloxyaminopropanols, butyrylcholinesterase, quaternary ammonium salts, tertiary amines,
- MeSH
- acetylcholinesterasa MeSH
- aktivace enzymů účinky léků MeSH
- benzoáty chemická syntéza chemie farmakologie MeSH
- butyrylcholinesterasa MeSH
- chemické modely MeSH
- cholinesterasové inhibitory chemická syntéza chemie farmakologie MeSH
- kvartérní amoniové sloučeniny chemická syntéza chemie farmakologie MeSH
- molekulární modely * MeSH
- soli chemie MeSH
- techniky syntetické chemie * MeSH
- vazba proteinů MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- acetylcholinesterasa MeSH
- benzoáty MeSH
- butyrylcholinesterasa MeSH
- cholinesterasové inhibitory MeSH
- kvartérní amoniové sloučeniny MeSH
- soli MeSH
Tertiary amines 3-(dialkylamino)-2-hydroxypropyl 4-[(alkoxycarbonyl)amino]benzoates and their quaternary ammonium salts were synthesized. The final step of synthesis of quaternary ammonium salts was carried out by microwave-assisted synthesis. Software-calculated data provided the background needed to compare fifteen new resulting compounds by their physicochemical properties. The acid dissociation constant (pKa) and lipophilicity index (log P) of tertiary amines were determined; while quaternary ammonium salts were characterized by software-calculated lipophilicity index and surface tension. Biological evaluation aimed at testing acetylcholinesterase and butyrylcholinesterase-inhibiting activity of synthesized compounds. A possible mechanism of action of these compounds was determined by molecular modelling study using combined techniques of docking; molecular dynamics simulations and quantum mechanics calculations.
Zobrazit více v PubMed
World Health Organization (WHO) Dementia. [(accessed on 24 August 2017)]; Available online: http://www.who.int/mediacentre/factsheets/fs362/en/
Pisani L., Farina R., Catto M., Iacobazzi R.M., Nicolotti O., Cellamare S., Mangiatordi G.F., Denora Nunzio S.R., Siragusa L., Altomare C.D., et al. Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents. J. Med. Chem. 2016;59:6791–6806. doi: 10.1021/acs.jmedchem.6b00562. PubMed DOI
Reitz Ch., Brayne C., Mayeux R. Epidemiology of Alzheimer disease. Nat. Rev. Neurol. 2011;7:137–152. doi: 10.1038/nrneurol.2011.2. PubMed DOI PMC
Novak P., Schmidt R., Kontsekova E., Zilka N., Kovacech B., Skrabana R., Vince-Kazmerova Z., Katina S., Fialova L., Prcina M., et al. Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer’s disease: A randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Neurol. 2017;16 doi: 10.1016/S1474-4422(16)30331-3. PubMed DOI
Wang D.-M., Feng B., Fu H., Liu A.L., Wang L., Du G.H., Wu S. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase. Molecules. 2017;22:172. doi: 10.3390/molecules22101658. PubMed DOI PMC
De Oliveira J.S., Husein A.F., Lopes D.G., Adeniyi A.S., Vidal P.T., Signor C., Da Silva B.J., Baldissarelli J., Suéling L.L., Pereira M.R., et al. Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer’s-like dementia: Involvement of acetylcholinesterase and cell death. NeuroToxicology. 2016;57:241–250. doi: 10.1016/j.neuro.2016.10.008. PubMed DOI
Dvir H., Silman I., Harel M., Rossenbery T., Sussman J. Acetylcholinesterase: From 3D structure to function. Chem.-Biol. Interact. 2010;187:10–22. doi: 10.1016/j.cbi.2010.01.042. PubMed DOI PMC
Padrtova T., Marvanova P., Mokry P. Quaternary Ammonium Salts—Synthesis and Use. Chem. Listy. 2017;111:197–205.
Mokry P., Zemanova M., Csöllei J., Racanska E., Tumova I. Synthesis and pharmacological evaluation of novel potential ultrashort-acting β-blockers. Pharmazie. 2003;58:18–21. PubMed
Connors S.P., Dennis P.D., Gill E.W., Terrar D.A. The Synthesis and Potassium Channel Blocking Activity of some (4-Methanesulfonamidophenoxy)propanolamines as Potential Class III Antiarrhythmic Agents. J. Med. Chem. 1991;34:1570–1577. doi: 10.1021/jm00109a007. PubMed DOI
Acevedo O., Jorgensen W.L. Exploring Solvent Effects upon the Menshutkin Reaction Using a Polarizable Force Field. J. Phys. Chem. 2010;114:8425–8430. doi: 10.1021/jp100765v. PubMed DOI PMC
Fan P., Terrier L., Hay A.-E., Marston A., Hosttetmann K. Antioxidant and enzyme inhibition activities and chemical profiles of Polygonum sachalinensis F.Schmidt ex Maxim (Polygonaceae) Fitoterapia. 2010;81:124–131. doi: 10.1016/j.fitote.2009.08.019. PubMed DOI
Xie Q., Zheng Z., Shao B., Fu W., Xia Z., Li W., Sun J., Zheng W., Zhang W., Sheng W., et al. Pharmacophore-based design and discovery of (−)-meptazinol carbamates as dual modulators of cholinesterase and amyloidogenesis. J. Enzym. Inhib. Med. Chem. 2017;32:659–671. doi: 10.1080/14756366.2016.1265521. PubMed DOI PMC
Morris G., Huey R., Lindstrom W., Sanner M., Belew R., Goodsell D., Olson A. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785–2791. doi: 10.1002/jcc.21256. PubMed DOI PMC
Case D.A., Darden T.A., Cheatham T.E., III, Simmerling C.L., Wang J., Duke R.E., Luo R., Walker R.C., Zhang W., Merz K.M., et al. AMBER 12 OR. University of California; San Francisco, CA, USA: 2012.
Bader R. Atoms in Molecules: A Quantum Theory. Oxford University Press; Oxford, UK: 1994.
Graham L.P. An Introduction to Medicinal Chemistry. Oxford University Press; Oxford, UK: 2009. pp. 599–604. Chapter 22.
Andujar S., Tosso R., Suvire F., Angelina E., Peruchena N., Cabedo N., Cortes D., Enriz D. Searching the “Biologically Relevant” Conformation of dopamine: A computational approach. J. Chem. Inf. Model. 2012;52:99–112. doi: 10.1021/ci2004225. PubMed DOI
Tosso Rodrigo D., Andujar S.A., Gutierrez L., Angelina E., Rodríguez R., Nogueras M., Baldoni H., Suvire F.D., Cobo J., Enriz D. Molecular modeling study of dihydrofolate reductase inhibitors. Molecular dynamics simulations, quantum mechanical calculations, and experimental corroboration. J. Chem. Inf. Model. 2013;53:2018–2032. doi: 10.1021/ci400178h. PubMed DOI
Párraga J., Cabedo N., Andujar S., Piqueras L., Moreno L., Galán A., Angelina E., Enriz D., Ivorra M.D., Sanz M.J., et al. 2,3,9- and 2,3,11-Trisubstituted tetrahydroprotoberberines as D2 dopaminergic ligands. Eur. J. Med. Chem. 2013;68:150–166. doi: 10.1016/j.ejmech.2013.07.036. PubMed DOI
Angelina E., Andujar S., Tosso R., Enriz D., Peruchena N. Non-covalent interactions in receptor-ligand complexes. A study based on the electron charge density. J. Phys. Org. Chem. 2014;27:128–134. doi: 10.1002/poc.3250. DOI
Párraga J., Andujar S.A., Rojas S., Gutierrez L.J., El Aouad N., Sanz M.J., Enriz D., Cabedo N., Cortes D. Dopaminergic isoquinolines with hexahydrocyclopenta[ij]-isoquinolines as D2-like selective ligands. Eur. J. Med. Chem. 2016;122:27–42. doi: 10.1016/j.ejmech.2016.06.009. PubMed DOI
Bar-On P., Millard C.B., Harel M., Dvir H., Enz A., Sussman J.L., Silman I. Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine. Biochemistry. 2002;41:3555–3564. doi: 10.1021/bi020016x. PubMed DOI
Wilson I., Hatch M.A., Ginsburg S. Carbamylation of acetylcholinesterase. J. Biol. Chem. 1960;235:2312–2315. PubMed
Wilson I., Harrison M.A., Ginsburg S. Carbamyl Derivatives of Acetylcholinesterase. J. Biol. Chem. 1961;236:1498–1500. PubMed
Deák K., Takács-Novák K., Kapás M., Vastag M., Tihanyi K., Noszál B. Physico-chemical characterization of a novel group of dopamine D3/D2 receptor ligands, potential atypical antipsychotic agents. J. Pharm. Biomed. Anal. 2008;48:678–684. doi: 10.1016/j.jpba.2008.06.021. PubMed DOI
Giaginis C., Tsantilli-Kakoulidou A. current state of the art in HPLC methodology for lipophilicity assessment of basic drugs. A review. J. Liquid Chromatogr. Relat. Technol. 2007;31:79–96. doi: 10.1080/10826070701665626. DOI
Lombardo F., Shalaeva M., Bissett B., Chistokhodova N. Physicochemical and biological profiling in drug research. ElogD7.4 20,000 compounds later: Refinements, observations, and applications. Pharmacokinet. Profil. Drug Res. 2006;187 doi: 10.1002/9783906390468.ch12. DOI
Poole S.K., Patel S., Dehring K., Workman H., Poole C.F. Determination of acid dissociation constants by capillary electrophoresis. J. Chromatogr. A. 2004;1037:445–454. doi: 10.1016/j.chroma.2004.02.087. PubMed DOI
Nowak P., Woźniakiewicz M., Kościelniak P. Application of capillary electrophoresis in determination of acid dissociation constant values. J. Chromatogr. A. 2015;1377:1–12. doi: 10.1016/j.chroma.2014.12.032. PubMed DOI
Andrasi M., Buglyo P., Zekany L., Gaspar A. A comparative study of capillary zone electrophoresis and pH-potentiometry for determination of dissociation constants. J. Pharm. Biomed. Anal. 2007;44:1040–1047. doi: 10.1016/j.jpba.2007.04.024. PubMed DOI
Tengler J., Kapustikova I., Pesko M., Govender R., Keltosova S., Mokrý P., Kollár P., O´Mahony J., Coffey A., Kráĺová K., et al. Synthesis and biological evaluation of 2-Hydroxy-3-[(2-aryloxyethyl)amino]propyl 4-[(Alkoxycarbonyl)amino]benzoates. Sci. World J. 2013 doi: 10.1155/2013/274570. PubMed DOI PMC
Luan F., Ma W., Zhang H., Zhang X., Liu M., Hu Z., Fan B. Prediction of pKa for neutral and basic drugs based on radial basis function neural networks and the heuristic method. Pharm. Res. 2005;9:1454–1460. doi: 10.1007/s11095-005-6246-8. PubMed DOI
Chemical Production Division Environmental Stewardship Branch; Canada: 2014. [(accessed on 25 August 2017)]. Reference Method for Measuring the Surface Tension of Chromium Electroplating, Chromium Anodizing and Reverse Etching Solutions with a Stalagmometer. Available online: https://www.ec.gc.ca/lcpe-cepa/E4899604-74FB-46D1-8E41-E3E24D6A7916/Methode-Reference-Method-eng.pdf.
Greenblatt H.M., Kryger G., Lewis T., Silman I., Sussman J.L. Structure of acetylcholinesterase complexed with (−)-galanthamine at 2.3 Å resolution. FEBS Lett. 1999;463:321–326. doi: 10.1016/S0014-5793(99)01637-3. PubMed DOI
Lindorff-Larsen K., Piana S., Palmo K., Maragakis P., Klepeis J., Dror R., Shaw D. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins Struct. Funct. Bioinform. 2010 doi: 10.1002/prot.22711. PubMed DOI PMC
Wang J., Wolf R., Caldwell J., Kollman P., Case D. Development and testing of a general amber force field. J. Comput. Chem. 2004;25:1157–1174. doi: 10.1002/jcc.20035. PubMed DOI
Jorgensen W., Chandrasekhar J., Madura J., Impey R., Klein M. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983;79:926–935. doi: 10.1063/1.445869. DOI
Essmann U., Perera L., Berkowitz M., Darden T., Lee H., Pedersen L. A smooth particle mesh Ewald method. J. Chem. Phys. 1995;103:8577–8593. doi: 10.1063/1.470117. DOI
Ryckaert J.-P., Ciccotti G., Berendsen H. Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. J. Comput. Phys. 1977;23:327–341. doi: 10.1016/0021-9991(77)90098-5. DOI
Izaguirre J., Catarello D., Wozniak J., Skeel R. Langevin stabilization of molecular dynamics. J. Chem. Phys. 2001;114:2090–2098. doi: 10.1063/1.1332996. DOI
The PyMOL Molecular Graphics System, Version 1.8. Schrödinger, LLC; New York, NY, USA: 2015.
Lu T., Chen F. Multiwfn: A multifunctional wavefunction analyzer. J. Comput. Chem. 2012;33:580–592. doi: 10.1002/jcc.22885. PubMed DOI
Novel Sulfonamide-Based Carbamates as Selective Inhibitors of BChE